Achieve Life Sciences Inc SP4P-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 05/07/24 CEST
4.38UNCH (UNCH)
52 week range
2.84 - 8.95
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.38
  • 52 Week High8.95
  • 52 Week High Date05/11/23
  • 52 Week Low2.84
  • 52 Week Low Date12/18/23

Key Stats

  • Market Cap162.18M
  • Shares Out34.25M
  • 10 Day Average Volume2.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change12.3

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.38
  • 52 Week High8.95
  • 52 Week High Date05/11/23
  • 52 Week Low2.84
  • 52 Week Low Date12/18/23
  • Market Cap162.18M
  • Shares Out34.25M
  • 10 Day Average Volume2.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change12.3

RATIOS/PROFITABILITY

  • EPS (TTM)-1.39
  • P/E (TTM)-3.15
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Achieve Life Sciences Inc

 

Profile

MORE
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of action that is both agonistic and antagonistic. Cytisinicline is a partial agonist...
Richard Stewart
Executive Chairman of the Board
John Bencich CPA
Chief Executive Officer, Director
Cindy Jacobs M.D., Ph.D
President, Director, Chief Medical Officer
Jerry Wan
Principal Accounting Officer, Senior Director, Accounting Operations
Address
22722 29TH DR. SE, SUITE 100
Seattle, WA
98021
United States